FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
7 letters match. Newest first.
-
DrugsPeak Performance Peptides
Peak Performance Peptides sold unapproved injectable peptide drugs, including semaglutide and retatrutide, without FDA approval.
High risk -
DrugsRoyal Peptides LLC
FDA warned Royal Peptides LLC that seven peptide products sold on its website are unapproved new drugs.
High risk -
DrugsNuScience Peptides LLC
FDA warned NuScience Peptides that it sells unapproved injectable peptide drugs, including GLP-1 and tesamorelin products, on its website.
High risk -
DrugsPeptide Partners LLC
Peptide Partners LLC sold seven unapproved injectable peptide drugs online with disease-treatment claims, FDA says.
High risk -
DrugsLovega LLC dba Pink Pony Peptides
FDA warned Pink Pony Peptides that its GLP-2 TZ, GLP-3 RT and Bacteriostatic Water are unapproved new drugs sold online.
High risk -
DrugsPrime Sciences
Prime Sciences sells injectable peptide drugs and BAC water online without FDA approval, FDA says.
High risk -
DrugsPekCura Labs
FDA warned PekCura Labs that its GLP-1-S, GLP-2-T, GLP-3-R, and bacteriostatic water products are unapproved new drugs sold online.
High risk